Project Details
Description
A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir versus Valganciclovir for the Prevention of Cytomegalovirus (CMV) Disease in CMV-seropositive Kidney Transplant Recipients who Received Anti
Status | Finished |
---|---|
Effective start/end date | 7/20/15 → 2/15/16 |
Funding
- CHIMERIX, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.